BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6657880)

  • 21. [Hyperprolactinemia].
    König MP; Kopp P
    Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sterility in hyperprolactinemic amenorrhea].
    Tscherne G; Urdl W
    Zentralbl Gynakol; 1983; 105(8):478-81. PubMed ID: 6868876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A predictive study of post-partum depression: some predisposing characteristics.
    Hayworth J; Little BC; Carter SB; Raptopoulos P; Priest RG; Sandler M
    Br J Med Psychol; 1980 Jun; 53(2):161-7. PubMed ID: 7387912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
    Romero C; León J; Jara R; González O
    Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy.
    Campagnoli C; Belforte L; Massara F; Peris C; Molinatti GM
    J Endocrinol Invest; 1981; 4(1):85-91. PubMed ID: 7240674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conception rate after gonadotropin therapy in hyperprolactinemia and normoprolactinemia.
    Farine D; Dor J; Lupovici N; Lunenfeld B; Mashiach S
    Obstet Gynecol; 1985 May; 65(5):658-60. PubMed ID: 3920594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.
    Thorner MO; Schran HF; Evans WS; Rogol AD; Morris JL; MacLeod RM
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1026-33. PubMed ID: 7189523
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of hyperprolactinemia in 70 women with amenorrhea.
    Potashnik G; Bar-Ziv J; Glick S; Shoham A; Ben-Aderet N
    Isr J Med Sci; 1978 Jul; 14(7):753-61. PubMed ID: 681167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
    Fukunaga T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
    Le Roith D; Potashnik G; Glick SM
    Int J Fertil; 1979; 24(2):145-7. PubMed ID: 40911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of lisuride in the treatment of hyperprolactinemic amenorrhea.
    Rojanasakul A; Sirimongkolkasem R; Chailurkit LO
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():42-6. PubMed ID: 2351912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
    Klibanski A; Greenspan SL
    N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bromocriptine on affect and libido in hyperprolactinemia.
    Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
    Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.